BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1318731)

  • 41. Toluene diisocyanate-induced asthma without airway hyperresponsiveness.
    Mapp CE; Dal Vecchio L; Boschetto P; De Marzo N; Fabbri LM
    Eur J Respir Dis; 1986 Feb; 68(2):89-95. PubMed ID: 3009212
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A longitudinal study of respiratory health of toluene diisocyanate production workers.
    Bodner KM; Burns CJ; Randolph NM; Salazar EJ
    J Occup Environ Med; 2001 Oct; 43(10):890-7. PubMed ID: 11665458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two cases of paraoccupational asthma due to toluene diisocyanate (TDI).
    De Zotti R; Muran A; Zambon F
    Occup Environ Med; 2000 Dec; 57(12):837-9. PubMed ID: 11077013
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amines: possible causative agents in the development of bronchial hyperreactivity in workers manufacturing polyurethanes from isocyanates.
    Belin L; Wass U; Audunsson G; Mathiasson L
    Br J Ind Med; 1983 Aug; 40(3):251-7. PubMed ID: 6307337
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mild improvement in symptoms and pulmonary function in a long-term follow-up of patients with toluene diisocyanate-induced asthma.
    Talini D; Novelli F; Bacci E; Costa F; Dente FL; Di Franco A; Malagrinò L; Vagaggini B; Paggiaro P
    Int Arch Allergy Immunol; 2013; 161(2):189-94. PubMed ID: 23343863
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Toluene diisocyanate occupational exposure data in the polyurethane industry (2005-2020): A descriptive summary from an industrial hygiene perspective.
    Sayles C; Finnegan N; Pike T; Spence MW
    Toxicol Ind Health; 2022 Sep; 38(9):606-621. PubMed ID: 35929225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epithelial folliculin is involved in airway inflammation in workers exposed to toluene diisocyanate.
    Pham DL; Trinh TH; Ban GY; Kim SH; Park HS
    Exp Mol Med; 2017 Nov; 49(11):e395. PubMed ID: 29147010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Medical Monitoring for Occupational Asthma Among Toluene Diisocyanate Production Workers in the United States.
    Cassidy LD; Doney B; Wang ML; Kurth L; Conner PR; Collins JJ; Carson M; Molenaar D; Redlich CA; Storey E
    J Occup Environ Med; 2017 Dec; 59 Suppl 12(Suppl 12):S13-S21. PubMed ID: 29200134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relationship between toluene diisocyanate exposure and respiratory health problems: A meta-analysis of epidemiological studies.
    Antoniou EE; Zeegers MP
    Toxicol Ind Health; 2022 Sep; 38(9):595-605. PubMed ID: 35543628
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two-year observation of pulmonary function in workers exposed to low concentrations of toluene diisocyanate.
    Omae K
    Int Arch Occup Environ Health; 1984; 55(1):1-12. PubMed ID: 6098561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diisocyanate emission from a paint product: a preliminary analysis.
    Jarand CW; Akapo SO; Swenson LJ; Kelman BJ
    Appl Occup Environ Hyg; 2002 Jul; 17(7):491-4. PubMed ID: 12083169
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mortality of workers exposed to toluene diisocyanate in the polyurethane foam industry.
    Schnorr TM; Steenland K; Egeland GM; Boeniger M; Egilman D
    Occup Environ Med; 1996 Oct; 53(10):703-7. PubMed ID: 8943836
    [TBL] [Abstract][Full Text] [Related]  

  • 53. On site comparison of the OSHA 42, Asset EZ4-NCO, Iso-Chek, DAN and CIP10 methods for measuring toluene diisocyanate (TDI) at a polyurethane foam factory.
    Aubin S; Hamdi EM; Joly A; Sarazin P; Lesage J; Breau L; Spence M; Gagné S
    J Occup Environ Hyg; 2020 May; 17(5):207-219. PubMed ID: 32275486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of solvent/derivatization agent systems for determination of extractable toluene diisocyanate from flexible polyurethane foam.
    Vangronsveld E; Berckmans S; Spence M
    Ann Occup Hyg; 2013 Jun; 57(5):640-9. PubMed ID: 23519948
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peak flow rate records in the diagnosis of occupational asthma due to isocyanates.
    Burge PS; O'Brien IM; Harries MG
    Thorax; 1979 Jun; 34(3):317-23. PubMed ID: 225841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Community exposure to toluene diisocyanate from a polyurethane foam manufacturing plant--North Carolina, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Jun; 47(22):455-7. PubMed ID: 9639366
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Toluene diisocyanate concentration investigation among TDI-related factories in Taiwan and their relations to the type of industry.
    Yeh HJ; Shih TS; Tsai PJ; Chang HY
    J Expo Anal Environ Epidemiol; 2002 Mar; 12(2):157-64. PubMed ID: 11965532
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between changes in diurnal variation of expiratory flows, lung volumes and respiratory symptoms after acute asthma.
    Boulet LP; Milot J; Turcotte H
    Respir Med; 1991 Nov; 85(6):487-93. PubMed ID: 1775675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidemiological measurement of bronchial responsiveness in polyurethane workers.
    Hendrick DJ
    Bull Eur Physiopathol Respir; 1987; 23(6):555-9. PubMed ID: 2840137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Absence of respiratory effects in subjects exposed to low concentrations of TDI and MDI.
    Musk AW; Peters JM; DiBerardinis L; Murphy RL
    J Occup Med; 1982 Oct; 24(10):746-50. PubMed ID: 6292385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.